logo.gif (2253 bytes)



Home Page

Welcome

Committees

Sponsors

Advance Program

Posters Sessions:

General
Information

Pre and Post Congress Tours

Registered Accompanying Persons Program

Accommodation

Accommodation and Tour Form

Registration Form

 

ADVANCE PROGRAM - Poster Session

WEDNESDAY, OCTOBER 4, 2000

08:30 - 12:30 

Poster Hall

Board No.  
P311:  PHARMACOTHERAPY
PHLOGENZYM CAN DELAY METABOLIC INJURIES OF MYOCARDIUM
A. Skutelis, E. Pule, I. Purvins, J. Baltkajs, J. Ansbergs, M. Skromanis, M. Zeibarts, V. Mikazhans, Riga, Latvia
THE RESULTS OF THROMBOLYTIC THERAPY IN PULMONARY EMBOLISM
N. Ekim, O. Oguzulgen, M. Cemri, A. Cengel, M. Kitapci, K. Demirel, Ankara, Turkey
3 VENTRICULAR FIBRILLATION DUE TO LONG QT SYNDROME PROBABLY CAUSED BY CLYNDAMYCIN
A. Gabel, Karlsruhe, Germany
THE EFFECT OF LIPID LOWERING THERAPY ON PLATELET FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE
C. Gurgun, C. Ceyhan, M. Zoghi, E. Ercan, O. Yavuzgil, M. Akin, C. Turkoglu,
Izmir, Turkey
ANTIPLATELET AGENT WAS THE ONLY EFFECTIVE DRUG TREATMENT TO PREVENT CARDIAC EVENTS IN PATIENTS WITH HEALED MYOCARDIAL INFARCTION COMPLICATED WITH VARIANT ANGINA
H. Ino, A. Kimura, N. Takeda, T. Watanabe, H. Furuta, T. Taniwa, H. Yabushita, M. Miyataka, K. Katayama, T. Takenaka, T. Hayashi, K. Kanamasa, K. Ishikawa,
Osaka, Japan
TOLERANCE OF EFFORT IN PATIENTS WITH CORONARY ARTERY DISEASE WITH ACE INHIBITORS IN THERAPY
T. Momcilov-Popin, D. Stojsic, J. Cikos, D. Zecevic, A. Stojsic-Milosavljevic, M. Potic, D. Zivkov Saponja, S. Ilic, B. Siriski, Sremska Kamenica, Yugoslavia
BOLUS VERSUS CONTINUOUS LOW DOSE OF ENALAPRILAT IN CONGESTIVE HEART FAILURE WITH ACUTE REFRACTORY DECOMPENSATION
M. Podbregar, G. Voga, M. Horvat, I. Zuran, B. Krivec, R. Skale, R. Pareznik, Celje, Slovenia
CYTOCHROME P450 (CYP) POLYMORPHISMS ARE ASSOCIATED WITH REDUCED WARFARIN DOSE
A. Rafii, B. Freeman, S. McGrath, T. Buchman, B. Zehnbauer, St. Louis MO, USA
ALLEVIATION OF MYOCARDIAL ISCHEMIA AFTER KAWASAKI DISEASE BY
HEPARIN AND EXERCISE
S. Tateno, M. Terai, T. Honda, T. Jibiki, K. Yasukawa, S. Oana, K. Niwa, Chiba, Japan
10 DOES THE ADDITION OF LOSARTAN IMPROVE THE BENEFICIAL EFFECTS OF
ACE-INHIBITORS IN PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION? A PILOT SUTY
P. Di Pasquale, V. Bucca, S. Scalzo, S. Cannizzaro, A. Giubilato, A. Tuttolomondo, A. Ortoleva, G. Follone, S. Paterna, Palermo, Italy
11  DOES THE ADDITION OF CANREONATE IMPROVE THE BENEFICIAL EFFECTS OF ACE-INHIBITORS IN PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION? A PILOT STUDY
P. Di Pasquale, S. Cannizzaro, A. Giubilato, M.G. Vitrano, P. Lo Verso, A. Pinto, A. Tuttolomondo, A. Ortoleva, G. Saccone, S. Paterna, Palermo, Italy
50  FLECAINID VERSUS DIGOXIN AND PLACEBO FOR THE CONVERSION OF RECENT ATRIAL FIBRILLATION
A. Kondili, I. Bella, A. Gace, Tirana, Albania
P312:  ACUTE MYOCARDIAL INFARCTION III
12  ASSOCIATION OF ACUTE RIGHT VENTRICULAR MYOCARDIAL INFARCTION WITH ACUTE INFERIOR MYOCARDIAL INFARCTION
M. Cemri, T. Timurkaynak, M. Ozdemir, B. Boyaci, R. Yalcin, I. Goksen, A. Cengel, O. Dortlemez, H. Dortlemez, Ankara, Turkey
13  PRIMARY AND RESCUE ANGIOPLASTY IN THE TREATMENT OF THE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
P. Chodor, H. Krupa, Z. Kalarus, B. Sredniawa, S. Pasyk, Zabrze, Poland
14  THE RELATIONSHIP BETWEEN CLINICAL AND ANGIOGRAPHIC FINDINGS IN REGARD TO THE PATTERN OF PRECORDIAL ST SEGMENT DEPRESSION IN INFERIOR WALL ACUTE MYOCARDIAL INFARCTION
L. Yildiran, G. Kabakci, M.K. Batur, R. Cagrikul, O. Onalan, L. Tokgozoglu, S. Aksoyek, K. Ovunc, A. Oto, N. Nazli, S. Kes, Ankara, Turkey
15  PROGNOSIS OF ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK DUE TO LEFT MAIN DISEASE
Z. Kalarus, P. Chodor, H. Krupa, O. Kowalski, J. Prokopczuk, T. Was, R. Lenarczyk, V. Kowalik, B. Borkowski, S. Pasyk, Zabrze, Poland
16  ASSOCIATION BETWEEN ACTIVITY AT ONSET OF SYMPTOMS AND OUTCOME OF ACUTE MYOCARDIAL INFARCTION
E. Hatzinikolaou, I. Kokani, E. Karapatsoudi, C.H. Tsevekidis, G. Maligos, G. Katsaris, Thessaloniki, Greece
17  CORONARY STENTING IN PATIENTS UNDERGOING PRIMARY PTCA: IMPROVEMENT IN CORONARY BLOOD FLOW AS MEASURED BY TIMI FRAME COUNT METHOD
G. Musumeci, A.S. Petronio, U. Limbruno, R. Baglini, G. Paterni, L. De Luca, P. Caravelli, M. Mariani, Pisa, Italy
18  PROGNOSIS AND COMPLICATIONS OF ACUTE CORONARY SYNDROMES IN PATIENTS OLDER THAN 80 YEARS OLD
B. Boyaci, M. Cemri, T. Timurkaynak, R. Yalcin, A. Cengel, O. Dortlemez, H. Dortlemez, Ankara, Turkey
19  EFFECT OF INTRAVENOUS NICORANDIL AFTER CORONARY REPERFUSION THERAPY IN ACUTE MYOCARDIAL INFARCTION: SALVAGE OF THE INFARCT MYOCARDIUM
K. Yoshida, T. Morooka, K. Kido, Y. Ohtsubo, K. Yoshida, S. Tsuji, T. Tokushima, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan
20  ST-T SEGMENTAL DEPRESSION IN RIGHT LEFT PRECORDIAL LEADS AS A PROGRAMS OF MYOCARDIAL INFARCT OF THE LOWER WALL
F.E. Guerra, L. Ramirez, P. Arreaza, M. Uzcategui, J. Casado, G. Inglessis, Maturin, Venezuela
21  LOW DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY IDENTIFYING VIABLE MYOCARDIUM AND PREDICT LEFT VENTRICLE FUNCTION AFTER PRIMARY PTCA
S. Jia, Y. Zhang, D. Hu, Y. Wu, Beijing, China
22  INFLUENCE OF INFARCT-ZONE VIABILITY ON LEFT VENTRICULAR REMODELING AFTER ACUTE MYOCARDIAL INFARCTION
Y. Zhang, S. Jia, D. Hu, Y. Wu, Beijing, China
P313:  ATHEROSCLEROSIS
23  REDUCTIVE METABOLISM OF PENTAERYTHRITOLTETRANITRATE TO NO ASSOCIATED WITH SUPPRESSION OF EXCESSIVE SUPEROXIDE PRODUCTION IN HYPERCHOLESTEROLEMIA
E.L. Bassenge, D. Stalleicken, B. Fink, Freiburg, Langenfeld, Germany
24  DISCRIMINATIVE VALUE OF MARKERS OF INFLAMMATION IN STABLE CORONARY HEART DISEASE
E. Verbraekel, D. De Bacquer, J. Delanghe, R. Mak, G. De Backer, Gent, Belgium
25  THE RELATIONSHIP BETWEEN THE EXTENT OF CORONARY ARTERY DISEASE AND ENDOTHELIAL FUNCTIONS
E. Ercan, C. Ceyhan, A. Akilli, C. Soydas Cinar, M. Akin, C. Turkoglu, Izmir, Turkey
26  AUTOANTIBODIES TITERS AGAINST OXIDIZED LDL IS NOT AN INDEX OF THE SEVERITY OF CORONARY ATHEROSCLEROSIS
I. Karabinos, S. Koulouris, A. Melpidou, I. Moshovitis, N. Papageorgakis, A. Kranidis, T. Gianoulis, P. Marousis, F. Symeonidis, A. Paraskevopoulos, Z. Zoulien, N. Exadaktylos, Athens, Greece
27  EFFECTS OF SYNTHETIC PROGESTIN ON NITRIC OXIDE BIOACTIVITY AND CYTOKINES IN POSTMENOPAUSAL WOMEN WITH RISK FACTORS FOR CORONARY ARTERY DISEASE
K.K. Koh, D. Jin, E.K. Shin, Inchon, South Korea
28  INFLUENCE OF HELICOBACTER PYLORI (HP) INFECTION
WITH VACUOLIZING CYTOTOXINE A ON RE-STENOSIS RATE IN PATIENTS AFTER PERCUTANEUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
M. Kowalsky, W. Rees, G. Fuhrmann, J. Thale, Bad Rothenfelde, Germany
29  AUTO-ANTIBODIES AGAINST ANTIGENS RELATED TO THE ENDOTHELIUM OR TO OXLDL IN ATHEROSCLEROSIS AND HYPERTENSION
J.E. Frostegard, U. de Faire, Stockholm, Sweden
P314:  CARDIAC SURGERY
30  EVIDENCE FOR DIFFUSE DISTAL CORONARY OBLITERATION AS THE MAJOR DETERMINANT OF IMPAIRED LEFT VENTRICULAR FUNCTION IN HEART RECIPIENTS WITH TRANSPLANT CORONARY ARTERY DISEASE
M. Dandel, M. Hummel, E. Wellnhofer, J. Mueller, R. Ewert, R. Hetzer, Berlin, Germany
31  ANEURYSMS OF AORTOCORONARY SAPHENOUS VEIN BYPASS GRAFTS
R. Demaria, J.M. Frapier, B. Albat, T. Aymard, P. Rouviere, N. Durrleman, P.A. Chaptal, Montpellier, France
32  CORRELATION OF FAS AND FAS LIGAND EXPRESSION WITH REJECTION STATUS OF TRANSPLANTED HEART IN HUMAN
S-I. Oh, I-W. Kim, I-H. Chae, H-S. Kim, B-H. Oh, Seoul, South Korea
51  GIANT ANEURYSM OF SAPHENOUS VEIN GRAFT TO CORONARY ARTERY COMPRESSING THE RIGHT ATRIUM
R. Kalimi, R.S. Palazzo, M. Graver, New York NY, USA
52  THE COMPARITION OF LONG TERM ANGIOGRAPHIC RESULTS OF STENT AND MICABG PROCEDURES FOR ONE VESSEL DISEASE PATIENTS
K. Kirali, B. Yaymaci, M.B. Rabus, O. Karakaya, R. Akdemir, B. Daglar,
G. Ipek, I. Dindar, F. Turan, C. Yakut , Istanbul, Turkey
P315: DIAGNOSTIC METHODS III
33  THE RELATION OF EXERCISE HYPERTENSION WITH ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE
A. Goda, M. Lezha, A. Dibra, E. Maci, A. Kamberi, M. Heba, Tirana, Albania
34  MYOCARDIAL BRIDGE AND MYOCARDIAL ISCHEMIA; COULD WE DEPEND ON TREADMILL EXERCISE?
C-W.R. Goh, I. Kim, H-K. Hwang, S-G. Hong, Bucheon, South Korea
35  USEFULNESS OF NEWLY DESIGNED PIGTAIL CATHETER WITH MULTIPLE SIDE HOLES
M. Hirose, K. Shimada, Y. Sakanoue, K. Hirata, K. Takeuchi, J. Yoshikawa,
Osaka, Japan
36  RELATIVE EXERCISE RESPONSE OF SYSTOLIC BLOOD PRESSURE IN MEN WITH HYPERTENSION AND CORONARY ARTERY DISEASE
A. Kamberi, M. Heba, M. Lezha, A. Goda, E. Zhuzhuni, E. Dado, V. Karajani,
Tirana, Albania
37  THE USE OF ELECTRON BEAM COMPUTED TOMOGRAPHY IN THE EVALUATION OF CHEST PAIN IN THE EMERGENCY DEPARTMENT
D.A. Laudon, J.F. Breen, L.F. Vukov, T. Behrenbeck, P.F. Sheedy, Rochester MN, USA
38  DIAGNOSTIC YIELD OF CHRONOTROPIC RESPONSE INDEX FOR THE DETECTION OF CORONARY ARTERY DISEASE
M. Lezha, A. Goda, A. Dibra, A. Kamberi, M. Heba, E. Maci, Tirana, Albania
39  MAGNETOCARDIOGRAPHY IN FOLLOW UP OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY RESULTS
S. Auth-Eisernitz, T. Hecker, I.A. Chaikovsky, J. Kohler, V.N. Sosnitsky, D. Groenemeyer, F. Steinberg, B. Heiler, Essen, Germany
40  REGIONAL BLOOD FLOW DIFFERENCES INDUCED BY HIGH DOSE DIPYRIDAMOLE EXPLAIN ETIOLOGY OF ANGINA
R.M. Fleming, Omaha NB, USA
41  THE USE OF CARDIOPULMONARY INDICES TO ASSESS PTCA RESULTS
E. Klainman, J. Lebzelter, G. Fink, M.R. Kramer, Petach Tikva, Israel
53  THE ROLE OF MYOCARDIAL PERFUSION SYNTHIGRAPHY FOR THE DETECTION OF STENOSIS IN MICABG TECHNIQUE FOR LAD BYPASSED PATIENTS
Bengi Yaymaci, Kaan Kirali, Onur Demirkol, Recep Akdemir, Sinan Dagdelen, Ismet Dindar, Cevat Yakut, Istanbul, Turkey
P316:  CARDIAC ASSIST DEVICES
42  COMPLEMENT AND CYTOKINE ACTIVATION DURING CARDIOPULMONARY BYPASS WITH HEPARIN-COATED EXTRACORPOREAL CIRCUITS
H. Fujii, S. Suehiro, T. Shibata, K. Hattori, H. Hirai, H. Kumano, T. Aoyama, H. Kinoshita, Osaka city, Japan
43  ENHANCED EXTERNAL COUNTERPULSATION WITH HEPARIN PRETREATMENT IMPROVES EXERCISE CAPACITY OF ANGINAL PATIENTS
M. Fujita, D. Masuda, R. Nohara, S. Sasayama, Kyoto, Japan
44  MECHANICAL VENTRICULAR SUPPORT IN CORONARY HEART DISEASE - FROM CENTRIFUGAL PUMP TO LION HEART
N. Reiss, A. El-Banayosy, L. Arusoglu, R. Korfer, Bad Oeynhausen, Germany
45  EFFECT OF ENHANCED EXTERNAL COUNTER PULSATION ON CRANIAL AND ABDOMINAL BLOOD FLOW
S. Karim, R. Setiadji, F. Santosa, R. Suwita, Jakarta, Indonesia
P317:  MYOCARDIAL ISCHEMIA, SILENT ISCHEMIA
46  PROGNOSTIC VALUE OF DIPYRIDAMOLE STRESS ECHOCARDIOGRAPHY FOR DETECTION OF SILENT MYOCARDIAL ISCHEMIA IN ASYMPTOMATIC DIABETIC PATIENTS
G. Derosa, R. Mattioli, E. Faglia, O. Gaddi, C. Dodi, E. Picano, Milano, Italy
47  DOES EXERCISE-INDUCED MYOCARDIAL ISCHAEMIA PREDICT STROKE?
S. Kurl, T.P. Tuomainen, T. Lakka, J. Laukkanen, J. Eranen, J. Sivenius, J.T. Salonen, Kuopio, Finland
48  EXERCISE-INDUCED SILENT MYOCARDIAL ISCHEMIA AND CORONARY MORTALITY IN MEN
J.A. Laukkanen, S. Kurl, T.A. Lakka, T. Tomi-Pekka, R. Rainer, S. Riitta, E. Jaakko, Kuopio, Finland
49  SILENT ISCHEMIA IN CASES WITH DIPPER OR NONDIPPER HYPERTENSION
S. Nalbantgil, H. Yilmaz, F. Ozerkan, C. Gurgun, R. Onder, I. Nalbantgil, Izmir, Turkey
54  EARLY COURSE OF HUMORAL IMMUNITY MARKERS IN ISCHEMIC HEART DISEASES
M. YazicI, M. Aydin, M. Tokac, A. Sokmen, A.Duzenli, M. Gul, H. Gok, Konya, Turkey
14:00 - 17:30 

Poster Hall

P321:  CARDIAC SURGERY II
MYOCARDIAL INFARCTION IN ON-PUMP, BEATING HEART CORONARY BYPASS GRAFTING - TECHNICAL ASPECTS
A. Borowski, H. Korb, Cologne, Germany
REOPERATION ON THE LAD: MIDCAB OR CONVENTIONAL BYPASS
J.M. Frapier, T. Aymard, J.L. Pasquier, R.G. Demaria, B. Albat, P.A. Chaptal, Montpellier, France
MYOCARDIAL INJURY DURING CORONARY ARTERY SURGERY ON THE BEATING HEART AND DURING CARDIOPLEGIC ARREST ASSESSED BY TROPONIN T RELEASE
J. Hooper, M. Kemp, L. Moran, T.W. Koh, G.S. Carr-White, A.C. DeSouza, F.D. Ferdinand, D.G. Gibson, J.R. Pepper, London, UK
BILATERAL SKELETONIZED INTERNAL THORACIC ARTERY GRAFTING IN PATIENTS WITH DIABETES MELLITUS
M. Matsa, Y. Paz, I. Shapira, J. Gurevitch, A. Kramer, D. Pevny, R. Mohr, Tel-Aviv, Israel
THE BENEFITS OF AVOIDING CARDIOPULMONARY BYPASS IN PATIENTS WITH SEVERE ATHEROMATOUS ASCENDING AORTA
O. Lev-Ran, M. Matsa, I. Shapira, J. Gurevitch, Y. Paz, D. Pevny, A. Kramer, C. Locker, R. Mohr, Tel-Aviv, Israel
CORONARY REOPERATIONS IN PATIENTS WITH A PATENT INTERNAL MAMMARY ARTERY GRAFT
l. Noyez, F.M. van Ecke, S.H. Skotnicki, R.M.H.J. Brouwer, Nijmegen, The Netherlands
ELASTICITY OF THREE TYPES OF CORONARY ARTERY BYPASS GRAFTS AFTER 6 MONTHS
S. Saenger, H.R. Zurbrugg, W. Bocksch, M. Musci, E. Fleck, J. Knorig, R. Hetzer, Berlin, Germany
MITRAL VALVE REPAIR IN SEVERE ISCHEMIC CARDIOMYOPATHY
D. Bitran, O. Merin, M.W. Klutstein, S. Od-Allah, N. Shapira, S. Silberman, Jerusalem, Israel
ABRUPT AORTIC ROOT DILATION SOON AFTER THE ROSS PROCEDURE -IS THIS A PROGRESSIVE PHENOMENON OR NOT?
M.V.T. Tantengco, R. Villavicencio, R.A. Humes, H.L. Walters III, Detroit MI, USA
10  THE UNCLAMPABLE ASCENDING AORTA IN CORONARY ARTERY SURGERY
M. Gaudino, F. Glieca, N. Luciani, F. Alessandrini, G. Possati, Rome, Italy
11  WARM BLOOD CARDIOPLEGIA AND NORMOTHERMIC CARDIOPULMONARY BYPASS - IS IT A MORE SUITABLE TECHNIQUE FOR CORONARY REVASCULARIZATION?
S. Mukai, Y. Kawaue, F. Nomura, Kure, Japan
12  FEASIBILITY AND EFFICACY OF OPCAB
F. Nomura, S. Mukai, Y. Fumimoto, K. Tamura, K. Ihara, Hiroshima, Japan
13  ECONOMIC ASPECTS AND BLOOD PRODUCT USE IN CARDIAC REVASCULARIZATION: COMPARISON OF ON- AND OFF-PUMP METHODS
C. Streinu, H. Machler, M. Anelli Monti, B. Rigler, Graz, Austria
14  LYMPHANGIOGENESIS AND DENERVATION AFTER TRANSMYOCARDIAL LASER REVASCULARIZATION IN HUMAN HEARTS - CLINICAL CONSEQUENCES
T. Wild, N. Serbecic, K. Schmid, R. Horvat, M. Mehrabi, H.D. Glogar, E. Glogar, Vienna, Austria
P322:  INTERVENTIONAL CARDIOLOGY AND IVUS
15  THE LONG TERM PROGNOSIS OF RESTENOSIS IN PATIENTS WITH INDWELLING PALMAZ-SCHATZ STENT (P-S STENT)
H. Akao, M. Kitayama, A. Fukuda, S. Ohkubo, S. Kanemitsu, N. Takekoshi, Kahoku, Japan
16  HETEROGENEITY OF PERIPHERAL VASCULAR ATHEROSCLEROSIS
A. Ali, V. Guduguntla, T. Schreiber, G. Kazmouz, J. Torey, S. Kazziha, Detroit MI, USA
17  EFFECTS OF CAPTOPRIL ADMINISTRATION IN CORONARY ARTERIAL DISTENSIBILITY OF ATHEROSCLEROTIC LESIONS. AN ICUS STUDY.
S.G. Deftereos, E.K. Karvouni, G.A. Lazaros, M. Foukarakis, N.M. Kouvousis, E.I. Rentoukas, A. Theodorakis, P. Zavitsanakis, E. Loizidis, A. Zacharoulis, Athens, Greece
18  COMPARISON OF SERUM C-REACTIVE PROTEIN AND AMYLOID-A LEVELS AFTER PRIMARY ANGIOPLASTY WITH STENT IMPLANTATION WITH REGARD TO RESTENOSIS RATE
S.G. Deftereos, E.K. Karvouni, M. Foukarakis, G.A. Lazaros, E.I. Rentoukas, N.M. Kouvousis, V. Krikos, A. Theodorakis, K. Kiriakoulis, A.A. Zacharoulis, Athens, Greece
19  LOCAL DRUG DELIVERY OF ONO-4007 INHIBITS NEOINTIMAL HYPERPLASIA IN DOGS
M. Fukuta, Y. Wakida, T. Iwa, M. Yonezu, Y. Suzuki, T. Ota, Y. Ozaki, T. Kobayashi, Nagakute, Japan
20  PATTERNS OF CORONARY PLAQUE BURDEN IN DIABETIC PATIENTS - A VOLUMETRIC INTRAVASCULAR ULTRASOUND STUDY
H. Gilutz, I. Tsameret, R. Ilia, P.J. Fitzgerald, P.G. Yock, Beer Sheva, Israel
21  EFFECTS OF CILOSTAZOL ON ANGIOGRAPHIC RESTENOSIS AFTER THE PALMAZ-SCHATZ STENT IMPLANTATION
K. Hara, Y. Ikari, H. Nakajima, Y. Kuroda, K. Tanabe, T. Tsuji, G. Nishimura, Y. Minatoya, J. Aoki, T. Watanabe, Tokyo, Japan
22  EFFECT OF RECOMBINANT SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 ON RESTENOSIS FOLLOWING ARTERIAL INJURY BY REPEAT ANGIOPLASTY IN PIGS
J.G. Bienvenu, J-F. Tanguay, J-F. Theoret, A. Kumar, R.G. Schaub, Y. Merhi, Montreal QC, Canada
23  LONG-TERM CLINICAL OUTCOME OF TENAX CORONARY STENT
E. El Moktar, K. Khalife, J. Fourcade, D. Carrie, G. Grollier, J.P. Monassier, M. Hamon, J.P. Rinaldi, B. Citron, V. Boulet, J. Lipiecki, L. Sarfaty, M. Hidrich, J. Puel, Toulouse, France
24  EFFECTIVELY OF THE PRIMARY TRANSLUMINAL CORONARY ANGIOPLASTY FOR TREATMENT TO THE ACUTE MYOCARDIAL INFARCTION (AMI). HOSPITAL ANALYSIS AND LATE OF 135 CONSECUTIVE CASES
C.A.M. Gottschall, R.E.G.S. Leite, Porto Alegre RS, Brazil
25  INSIGHTS INTO CORONARY RESTENOSIS
C.A.M. Gottschall, V. Miller, R.E.G.S. Leite, Porto Alegre RS, Brazil
26  THE USE OF EPTIFIBATIDE WITH PRIMARY STENTING FOR ACUTE MYOCARDIAL INFARCTION
G.S. Ledley, R. Maraj, N. Pilatis, P. Rerkpattanapipat, M.N. Kotler, Philadelphia PA, USA
27  ULTRASOUND ANGIOPLASTY OF PERIPHERAL ARTERIES: NOVEL CAPABILITIES AND PROSPECTS FOR ADVANCEMENT
A.G. Mrochek, I.E. Adzerikho, Y.P. Tarakanov, V.T. Minchenya, V.I. Stelmashok, A.I. Savchuk, Minsk, Belarus
28  EFFICACY OF TRANSRADIAL CORONARY INTERVENTION AS A TREATMENT FOR ACUTE MYOCARDIAL INFARCTION
Y. Murase, H. Ishihara, Y. Suzuki, A. Hirashiki, H. Umeda, T. Tanaka, H. Kanda, Aichi, Japan
29  CARDIAC TROPONIN T, CREATINE KINASE, AND ITS ISOFORM RELEASE AFTER APPARENTLY SUCCESSFUL CORONARY STENTING WTH OR WITHOUT PREDILATION
T. Timurkaynak, M. Ozdemir, M. Cemri, R. Yalcin, B. Boyaci, A. Cengel, O. Dortlemez, Ankara, Turkey
30  INTRACORONARY ULTRASOUND CHARACTERISTICS OF ATHEROSCLEROTIC LESION MORPHOLOGY IN PATIENTS WITH ANGIOGRAPHICALLY SILENT CORANARY ARTERY DISEASE
S. Pasyk, T. Zielinska, A. Duszanska, M. Swierad, H. Krupa, M. Szewczyk, Zabrze, Poland
31  VALUE OF CORONARY FLOW RESERVE IMMEDIATELY AFTER STENTING ON THE ASSESSMENT OF LATE OUTCOME
J. Qian, J. Ge, H. Chen, D. Baumgart, M. Haude, S. Sack, R. Erbel, Shanghai, China, Essen, Germany
32  COMPARISON OF 6F AND 8F GUIDING CATHETERS FOR ACUTE MI INTERVENTIONS
J. Fox, K. Ravi, C. Reimers, A. Kasatkin, W. Sherman, New York NY, USA
33  COMPARISON OF HEPARIN-COATED JOMED STENTS WITH UNCOATED STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE
M. Degertekin, M. Gencbay, K. Sonmez, F. Turan, Istanbul, Turkey
P323:  RISK FACTORS FOR CORONARY ARTERY DISEASE
34  PECULIARITIES OF RISK FACTORS OF ANGINA PECTORIS IN WEST AFRICA
J-B. Anzouan-Kacou, C. Aboua-Eboule, M. Bassa, I. Coulibaly, K.E. Kramoh, E. Siransy, R. Abouo-Ndori, Abidjan, Ivory Coast
35  INFLUENCE OF CARDIOVASCULAR RISK FACTORS ON VASCULAR REMODELING IN ATHEROSCLEROTIC LESIONS
R. Fuessl, H.H. Osterhues, J. Woehrle, E. Kranenberg, U. Kiausch, M. Hoeher, F.M. Baer, H.W. Hoepp, Ulm, Germany
36  EFFECTS OF SYNTHETIC PROGESTIN ON NITRIC OXIDE BIOACTIVITY AND MARKERS OF INFLAMMATION IN POSTMENOPAUSAL WOMEN WITH RISK FACTORS FOR CORONARY ARTERY DISEASE
K.K. Koh, D. Jin, J.Y. Ahn, I.S. Choi, E.K. Shin, Inchon, South Korea
37  OVERWEIGHT AND OBESITY IN NOVOSIBIRSK POPULATION: 10-YEARS TRENDS AND RESULTS OF PROSPECTIVE STUDY (SIBMONICA)
E. Kylbanova, S. Malyutina, Y. Nikitin, Yakutsk, Russia
38  THE EVALUATION OF CORRELATION BETWEEN HUMMAN,S PLASMA,S VITAMIN C AND SOME PLASMA LIPOPROTEINS CONCENTRATIONS [LDL/HDL/ TOTALCHOLESTROL TRIGLYCERID]
H. Maddad, Tehran, Iran
39  RISK FACTOR CHANGES 1991 TO 1999: RESULTS FROM A CINDI REGION IN WESTERN AUSTRIA
H. Ulmer, E. Ruttmann, G. Diem, H-P. Bischof, K. Huber, D. Mostegl, H. Concin, Innsbruck, Austria
40  HOMEOSTASIS MODEL ASSESSMENT (HOMA) IN TYPE 2 DIABETIC PATIENTS
F. Contreras, V. Bermudez, C. Cano, A. Souki, M. Medina, M. Lemus, E. Leal, N. Arias, M. Ambar, M. Nunez, J. Andrade, M. Arria, F. Bermudez, M. De la Parte, M. Velasco, Caracas, Venezuela
41  CARDIOVASCULAR RISK FACTORS AND OCCUPATION IN A RURAL ITALIAN POPULATION
M.F. Vescio, S. Giampaoli, Roma, Italy
42  ADULTS IN POLAND UNDERESTIMATE CARDIOVASCULAR RISKS OF SEDENTARY LIFESTYLE AND PROFITS OF REGULAR PHYSICAL ACTIVITY
T.R. Zdrojewski, M. Kakol, K. Kozicka, B. Wyrzykowski, B. Krupa-Wojciechowska, Gdansk, Poland
43  NUTRITIONAL INFLUENCE ON THE ATHEROGENIC RISK FACTORS IN WOMEN
N. Kakauridze, N. Kipshidze, Tbilisi, Georgia
P323:  RISK FACTORS FOR CORONARY ARTERY DISEASE
44  MAIN FEATURES OF CORONARY HEART DISEASE IN WOMEN
V. Mendes, A. Felix, M. Monteiro, C. Barradas, A. Sousa, I. Joao, J. Sa Nogueira, A. Aleixo, Lisbon, Portugal
45  NATIONALITY DIFFERENCE IN THE DISTRIBUTIONS OF SERUM LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS LEVEL IN XINJIANG, CHINA
Y. Zou, H. Bingxian, H. Dayi, Beijing, China
P324:  ACUTE CORONARY SYNDROMES II
46  PARASYMPATHETIC IMPAIRMENT IN PATIENTS WITH CARDIAC SYNDROME X
A. Cevese, G. Gulli, R. Cemin, C. Vassanelli, Verona, Italy
47  POSITIVE CORRELATION BETWEEN PLASMA FIBRINOGEN AND TROPONIN I IN PATIENTS WITH ACUTE CORONARY SYNDROME
M. Gil, M. Zarebinski, J. Adamus, Warsaw, Poland
48  PLASMA FIBRINOGEN IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE
M. Gil, M. Zarebinski, J. Adamus, Warsaw, Poland
49  PATIENT PERCEPTION AND LIFESTYLE MODIFICATION AFTER AN ACUTE CORONARY SYNDROME
R. Yuval, K. Uziel, N. Gordon, R. Pikan-Shalem, M.Y. Flugelman, D.A. Halon, B.S. Lewis, Haifa, Israel
P325:  ACUTE MYOCARDIAL INFARCTION AND REPERFUSION I
50  EFFECT OF P-SELECTIN ANTAGONISTS ON THE DEVELOPMENT OF THROMBI IN BLOOD VESSELS
M.J. Eppihimer, R.G. Schaub, Andover MA, USA
51  THE EFFECT OF THROMBOLYTIC THERAPY ON QT DISPERSION AND MEAN PLATELET VOLUME IN ACUTE MYOCARDIAL INFARCTION
M.K. Erol, M. Acikel, E. Bozkurt, H. Senocak, Erzurum, Turkey
52  NON-INVASIVE REPERFUSION ASSESSMENT BY CONTINUOUS VECTORCARDIOGRAPHY AFTER THROMBOLYTIC THERAPY IN AMI ENABLES EARLY PROGNOSTICATION AND IS SUPERIOR TO REPEATED ECG
S. Gill, B. Haastrup, T. Haghfelt, P. Clemmensen, Odense, Denmark
53  CONJUNCTIVE TREATMENT WITH RECOMBINANT P-SELECTIN GLYCOPROTEIN LIGAND-1 ENHANCES THROMBOLYSIS IN A PORCINE MODEL.
A. Kumar, M.P. Villani, J.C. Keith, Jr., R.G. Schaub, Andover MA, USA
54  ADJUNCTIVE TREATMENT WITH RPSGL-IG AND/OR EPTIFIBATIDE IN A CANINE MODEL OF THROMBOLYSIS
A. Kumar, M.P. Villani, H. Zhang, J.C. Keith, Jr., R.G. Schaub, Andover MA, USA
55  RECOMBINANT SOLUBLE P-SELECTIN GLYCOPROTEIN LIGAND-1 HAS A THROMBOLYTIC EFFECT IN A RAT MODEL OF THROMBOSIS
H. Zhang, R.G. Schaub, J.C. Keith, Jr., A. Kumar, Andover MA, USA
56  EXTERNAL THERAPEUTIC ULTRASOUND ACCELERATES THROMBOLYSIS IN CANINE FEMORAL THROMBUS MODEL
J. Bai, X. Shen, R. Jia, Z. Li, H. Chen, Shanghai, China
57  EXTERNAL THERAPEUTIC ULTRASOUND COMBINED WITH HALF DOSE OF RSK ACCELERATES THROMBOLYSIS IN RABBIT FEMORAL ATERIAL THROMBOSIS
J. Bai, X. Shen, N. Cai, Shanghai, China
58  OXYGEN DERIVED FREE RADICALS ACTIVITY FOLLOWING THROMBOLYSIS WITH STREPTOKINASE, T-PA & R-PA COMBINED WITH ABCIXIMAB
E. Goldhammer, S. Shnizer, N. Kleiman, A. Lanir, E.G. Abinader, Haifa, Israel
P326:  ATHEROSCLEROSIS II
59  RELATION BETWEEN CLASSICAL CORONARY RISK FACTORS AND C REACTIVE PROTEIN IN THE NORMAL POPULATION
J. De Backer, D. De Bacquer, E. Verbraekel, R. Mak, J. Delanghe, M. Kornitzer, G. De Backer, Gent, Belgium
60  IS HIGH FIBRINOGEN LEVELS AN INDEPENDENT NEW RISK FACTOR IN CORONARY ARTERY DISEASE?
K. Gemici, Y. Ilcol, M. Gurbuz, I. Baran, J. Cordan, Bursa, Turkey
61  ANGER PRONENESS AND CAROTID ARTERY ATHEROSCLEROSIS: A POSSIBLE MECHANISM FOR CARDIOVASCULAR DISEASE
J.E. Williams, A. Folsom, Atlanta GA, USA, D. Couper, J. Nieto, H. Tyroler
P327:  ACUTE MYOCARDIAL INFARCTION AND REPERFUSION II
62  FACTORS INFLUENCING THE THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
S. Cagan, I. Riecansky, T. Trnovec, O. Jurkovicova, Z. Motovska, S. Wimmerova, Bratislava, Slovak Republic
63  INCIDENCE OF HAEMORRHAGIC STROKE IN FIBRINOLYTIC TREATED PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION. TIM STUDY: A SUBGROUP ANALYSIS
L. Lopez, J.M. Cruz, A. Cabades, A. Castro, D. Garcia, V. Lopez, L. Martin, J. Velasco, C. Navas, F. Torres, C. Kalmeller, Madrid, Spain
64  SERIAL CHANGES OF PLASM ET-1 LEVEL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY PTCA AND RESCUE PTCA
S. Jia, J. Peng, D. Hu, T. Li, M. Yang, L. Wang, F. Chen, Y-C. Zhang, Beijing, China
 

This site was developed by .